Literature DB >> 6456060

Multivariate analysis of T-cell functional defects and circulating serum factors in Hodgkin's disease.

R S Schulof, R S Bockman, J A Garofalo, C Cirrincione, S Cunningham-Rundles, G Fernandes, N K Day, C M Pinsky, G S Incefy, H T Thaler, R A Good, S Gupta.   

Abstract

A comprehensive immunologic and serologic analysis was performed on 31 untreated patients with Hodgkin's disease. Immune evaluations stressed T-cell functional activity and included traditional parameters (PHA responsiveness and delayed hypersensitivity skin reactivity), as well as newer functional assays (T-cell colony formation, chemotaxis, spontaneous and antibody-dependent cytotoxicity, and concanavalin A-induced suppressor cell activity (CISA). Serum factors included ferritin, prostaglandins, zinc, copper, immune complexes, and thymic hormone activity. Every patient exhibited at least one T-cell or serum abnormality. The greatest percentage of patients exhibited T-cell defects in chemotaxis (85%), colony formation (81%). and PHA reactivity (64%). Immune defects were more common with advanced disease but were not related to absolute T-cell or monocyte count, skin test anergy, or abnormalities of T mu/T gamma cell proportions. Linear relationships were identified among abnormalities in the three assays employing mononuclear cells (PHA, colony formation, CISA) which may have reflected the inhibitory influence of monocytes present in the mononuclear cell preparations. Low serum zinc correlated with marked impairment of T-cell chemotaxis. Elevated prostaglandins were associated with high PHA reactivity and with depressed colony formation. Our results indicate that many complex factors, including intrinsic T-cell defects, contribute to the impaired immunity associated with Hodgkin's disease.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6456060     DOI: 10.1002/1097-0142(19810815)48:4<964::aid-cncr2820480419>3.0.co;2-b

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  5 in total

1.  Bone marrow and peripheral blood natural killer cell activity in lymphomas. Its response to IL-2.

Authors:  L H Caldera; M Leon-Ponte; G Acquatella; N E Bianco; I Blanca
Journal:  Clin Exp Immunol       Date:  1992-04       Impact factor: 4.330

2.  The detection of Epstein-Barr virus in hairy cell leukemia cells by in situ hybridization.

Authors:  B C Wolf; A W Martin; R S Neiman; A J Janckila; L T Yam; A Caracansi; B A Leav; R Winpenny; D S Schultz; H J Wolfe
Journal:  Am J Pathol       Date:  1990-03       Impact factor: 4.307

3.  Immunorestorative properties of thymostimulin (TS) in patients with Hodgkin's disease in clinical remission.

Authors:  A M Liberati; M Brugia; B S Edwards; P Bertoni; E Ballatori; A Puxeddu; F Grignani
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

4.  Monocyte-dependent serum suppression of lymphocyte blastogenesis in Hodgkin's disease: an association with nephrotic syndrome.

Authors:  J P Crowley; H J Ree; A Esparza
Journal:  J Clin Immunol       Date:  1982-10       Impact factor: 8.317

5.  Spontaneous and Concanavalin A-induced suppressor activity in control and Hodgkin's disease patients.

Authors:  A N Akbar; D B Jones; D H Wright
Journal:  Br J Cancer       Date:  1984-03       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.